£66.00

Praeger Advances in Psychedelic Medicine: State-of-the-Art Therapeutic Applications

Price data last checked 15 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£66 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 76 days • 76 data points (No recent data available)

Historical
Generating forecast...
£76.72 £64.93 £67.50 £70.07 £72.65 £75.22 £77.79 24 March 2026 11 April 2026 30 April 2026 19 May 2026 07 June 2026

Price Distribution

Price distribution over 76 days • 2 price levels

Days at Price
Current Price
3 days · current 73 days 0 18 37 55 73 £66 £77 Days at Price

Price Analysis

Most common price: £77 (73 days, 96.1%)

Price range: £66 - £77

Price levels: 2 different prices over 76 days

Description

Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psychological, physiological, and social problems. More than a decade ago, the U.S. government lifted its ban on all testing of psychedelic substances. Winkelman and Sessa now provide updated scientific research and applications of these substances, now moving into approved categories of medicine. The text is an up-to-date assessment of the latest advances in the field of psychedelic medicine, covering the use of LSD, psilocybin, MDMA, ayahuasca, and other substances to augment psychotherapies for a range of disorders. It discusses medical and psychiatric concerns, clinical efficacy and safety, ethical considerations, and neuroscience findings regarding the psychedelic compounds. Topics covered include an overview of psychiatric applications of psychedelics; treatments for addictions and depressive disorders; effects of psychedelics on inflammation and neuroplasticity; evidence for clinical applications of DMT, ayahuasca, and cannabidiol; psychedelic treatment of sociopathic disorders; microdosing psychedelics; training psychedelic therapists; and community-based harm reduction approaches to managing psychedelic crises.

Product Specifications

Brand
Praeger
Format
hardcover
Domain
Amazon UK
Release Date
22 March 2019
Listed Since
01 November 2018

Barcode

No barcode data available

Similar Products You Might Like

The Therapeutic Use of Ayahuasca
83% match

The Therapeutic Use of Ayahuasca

Springer

£107.85 15 May 2026
Clinical Manual of Addiction Psychopharmacology
79% match

Clinical Manual of Addiction Psychopharmacology

American Psychiatric Association Publishing

£58.30 29 May 2026
Experimental Psychopharmacology (Contemporary Neuroscience)
79% match

Experimental Psychopharmacology (Contemporary Neuroscience)

Humana

£126.39 04 Jun 2026
The Practitioner's Guide to Psychoactive Drugs
78% match

The Practitioner's Guide to Psychoactive Drugs

Springer

£85.30 02 Jun 2026
Clinical Psychopharmacology: A Practical Approach
78% match

Clinical Psychopharmacology: A Practical Approach

World Scientific Publishing Company

£77.87 20 May 2026
Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS
78% match

Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS

Routledge

£104.07 19 May 2026
A Scientific Assessment of the Validity of Mystical Experiences: Understanding Altered Psychological and Neurophysiological States (Routledge Research in Psychology)
78% match

A Scientific Assessment of the Validity of Mystical Experiences: Understanding Altered Psychological and Neurophysiological States (Routledge Research in Psychology)

Routledge

£41.58 05 Jun 2026
Electrophysiology and Psychophysiology in Psychiatry and Psychopharmacology: 21 (Current Topics in Behavioral Neurosciences, 21)
78% match

Electrophysiology and Psychophysiology in Psychiatry and Psychopharmacology: 21 (Current Topics in Behavioral Neurosciences, 21)

Springer

£107.98 30 May 2026
Psychedelic Harm Reduction (Current Topics in Behavioral Neurosciences, 77)
77% match

Psychedelic Harm Reduction (Current Topics in Behavioral Neurosciences, 77)

Springer

£144.99 20 May 2026
Non Invasive Brain Stimulation in Psychiatry and Clinical Neurosciences
77% match

Non Invasive Brain Stimulation in Psychiatry and Clinical Neurosciences

Springer

£86.87 06 Jun 2026
Prohibition, Religious Freedom, and Human Rights: Regulating Traditional Drug Use
77% match

Prohibition, Religious Freedom, and Human Rights: Regulating Traditional Drug Use

Springer

£107.98 01 Jun 2026
Herbal Medicine in Depression: Traditional Medicine to Innovative Drug Delivery
77% match

Herbal Medicine in Depression: Traditional Medicine to Innovative Drug Delivery

Springer

£155.88 14 May 2026
Explosions in the Mind: Composing Psychedelic Sounds and Visualisations (Palgrave Studies in Sound)
77% match

Explosions in the Mind: Composing Psychedelic Sounds and Visualisations (Palgrave Studies in Sound)

MACMILLAN

£75.06 06 Jun 2026
Pediatricians and Pharmacologically Trained Psychologists: Practitioner’s Guide to Collaborative Treatment
77% match

Pediatricians and Pharmacologically Trained Psychologists: Practitioner’s Guide to Collaborative Treatment

Springer

£122.77 05 Jun 2026
Neuropsychology and Substance Use: State-of-the-Art and Future Directions (Studies on Neuropsychology, Neurology and Cognition)
77% match

Neuropsychology and Substance Use: State-of-the-Art and Future Directions (Studies on Neuropsychology, Neurology and Cognition)

Routledge

£56.85 29 May 2026
Intervening in the Brain: Changing Psyche and Society: 29 (Ethics of Science and Technology Assessment, 29)
77% match

Intervening in the Brain: Changing Psyche and Society: 29 (Ethics of Science and Technology Assessment, 29)

Springer

£52.66 12 May 2026
Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders
77% match

Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders

Springer

£111.83 31 May 2026
The Expanding World Ayahuasca Diaspora: Appropriation, Integration and Legislation (Vitality of Indigenous Religions)
77% match

The Expanding World Ayahuasca Diaspora: Appropriation, Integration and Legislation (Vitality of Indigenous Religions)

Routledge

£44.75 21 May 2026
Major Depressive Disorder: Rethinking and Understanding Recent Discoveries: 1305 (Advances in Experimental Medicine and Biology, 1305)
77% match

Major Depressive Disorder: Rethinking and Understanding Recent Discoveries: 1305 (Advances in Experimental Medicine and Biology, 1305)

Springer

£111.72 01 Jun 2026
Seminars in the Psychotherapies (College Seminars Series)
77% match

Seminars in the Psychotherapies (College Seminars Series)

Cambridge University Press

£41.77 03 Jun 2026
Childhood Stress, Trauma and Synapse Loss
77% match

Childhood Stress, Trauma and Synapse Loss

Springer

£114.06 31 May 2026
76% match

Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management

Academic Press

£133.99 22 May 2026
Psychopharmacology of the Developmental Disabilities (Disorders of Human Learning, Behavior, and Communication)
76% match

Psychopharmacology of the Developmental Disabilities (Disorders of Human Learning, Behavior, and Communication)

Springer

£76.38 01 Jun 2026
Cannabis in Medicine: An Evidence-Based Approach
76% match

Cannabis in Medicine: An Evidence-Based Approach

Springer

£62.21 17 May 2026